These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15619510)

  • 21. Drugs for the control of parasitic diseases: current status and development in schistosomiasis.
    Fenwick A; Savioli L; Engels D; Robert Bergquist N; Todd MH
    Trends Parasitol; 2003 Nov; 19(11):509-15. PubMed ID: 14580962
    [No Abstract]   [Full Text] [Related]  

  • 22. The Mechanism of Action of Praziquantel: Can New Drugs Exploit Similar Mechanisms?
    Thomas CM; Timson DJ
    Curr Med Chem; 2020; 27(5):676-696. PubMed ID: 30259811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Could we expect new praziquantel derivatives? A meta pharmacometrics/pharmacoinformatics analysis of all antischistosomal praziquantel derivatives found in the literature.
    da Silva VBR; Boucherle B; El-Methni J; Hoffmann B; da Silva AL; Fortune A; de Lima MDCA; Thomas A
    SAR QSAR Environ Res; 2019 Jun; 30(6):383-401. PubMed ID: 31144535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schistosomiasis: challenges for control, treatment and drug resistance.
    Fenwick A; Webster JP
    Curr Opin Infect Dis; 2006 Dec; 19(6):577-82. PubMed ID: 17075334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence and level of endogenous expression of calcium channel beta subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel.
    Valle C; Troiani AR; Festucci A; Pica-Mattoccia L; Liberti P; Wolstenholme A; Francklow K; Doenhoff MJ; Cioli D
    Mol Biochem Parasitol; 2003 Aug; 130(2):111-5. PubMed ID: 12946847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in development of new antischistosomal drugs in recent years].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Jun; 28(3):218-25. PubMed ID: 20806509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the mechanism of action of praziquantel and how might resistance strike?
    Cupit PM; Cunningham C
    Future Med Chem; 2015; 7(6):701-5. PubMed ID: 25996063
    [No Abstract]   [Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents.
    Yang JJ; Boissier J; Chen JL; Yao H; Yang S; Rognon A; Qiao C
    Future Med Chem; 2015; 7(6):713-25. PubMed ID: 25996065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
    Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
    ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ca²⁺ channels and praziquantel: a view from the free world.
    Chan JD; Zarowiecki M; Marchant JS
    Parasitol Int; 2013 Dec; 62(6):619-28. PubMed ID: 23246536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-positioning protein-kinase inhibitors against schistosomiasis.
    Gelmedin V; Dissous C; Grevelding CG
    Future Med Chem; 2015; 7(6):737-52. PubMed ID: 25996067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel.
    Abo-Ghalia MH; Soliman AE
    Arzneimittelforschung; 1996 Feb; 46(2):207-9. PubMed ID: 8720316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
    Wang Y; Xu J; Xia C
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-Based Study of Natural Products with Anti-Schistosoma Activity.
    Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN
    Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel.
    Cao H; Liu H; Dömling A
    Chemistry; 2010 Nov; 16(41):12296-8. PubMed ID: 20845417
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory].
    Liang YS; Li HJ; Dai JR; Wang W; Qu GL; Tao YH; Xing YT; Li YZ; Qian K; Wei JY
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Dec; 23(6):605-10. PubMed ID: 22379812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective?
    Dissous C; Grevelding CG
    Trends Parasitol; 2011 Feb; 27(2):59-66. PubMed ID: 20920890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of a new antischistosomally active and toxicologically tolerant C-12 monothione surrogate of the universal antihelmintic praziquantel.
    Abo-Ghalia MH; Soliman AM
    Acta Pol Pharm; 2002; 59(4):313-20. PubMed ID: 12403307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent Inhibitors of Thioredoxin Glutathione Reductase: Grail of Anti-Schistosome Drug within Reach?
    Tripathi T; Chetri PB
    ACS Infect Dis; 2020 May; 6(5):893-895. PubMed ID: 32159329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.